BG63571B1 - (r)-(z)-1-азабицикло[2.2.1] хептан-3-он,о-[3-(3-метоксифенил)-2-пропинил] оксим малеат като фармацевтично средство - Google Patents

(r)-(z)-1-азабицикло[2.2.1] хептан-3-он,о-[3-(3-метоксифенил)-2-пропинил] оксим малеат като фармацевтично средство Download PDF

Info

Publication number
BG63571B1
BG63571B1 BG102078A BG10207897A BG63571B1 BG 63571 B1 BG63571 B1 BG 63571B1 BG 102078 A BG102078 A BG 102078A BG 10207897 A BG10207897 A BG 10207897A BG 63571 B1 BG63571 B1 BG 63571B1
Authority
BG
Bulgaria
Prior art keywords
maleate
salt
compound
pentane
oxime
Prior art date
Application number
BG102078A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG102078A (en
Inventor
Howard ANDO
Stephen Barrett
Juan JEAN
Steven Rose
Haile Tecle
Original Assignee
Warner-Lambert Company Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner-Lambert Company Llc filed Critical Warner-Lambert Company Llc
Publication of BG102078A publication Critical patent/BG102078A/xx
Publication of BG63571B1 publication Critical patent/BG63571B1/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BG102078A 1995-06-07 1997-11-27 (r)-(z)-1-азабицикло[2.2.1] хептан-3-он,о-[3-(3-метоксифенил)-2-пропинил] оксим малеат като фармацевтично средство BG63571B1 (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/474,622 US5534522A (en) 1995-06-07 1995-06-07 (R)-(Z)-1-azabicyclo [2.2.1] heptan-3-one,O-[3-(3-methoxyphenyl)-2-propynyl] oxime maleate as a pharmaceutical agent
PCT/US1996/006814 WO1996040687A1 (en) 1995-06-07 1996-05-13 (r)-(z)-1-azabicyclo[2.2.1]heptan-3-one,o-[3-(3-methoxyphenyl)-2-propynyl]oxime maleate as a pharmaceutical agent

Publications (2)

Publication Number Publication Date
BG102078A BG102078A (en) 1998-11-30
BG63571B1 true BG63571B1 (bg) 2002-05-31

Family

ID=23884337

Family Applications (1)

Application Number Title Priority Date Filing Date
BG102078A BG63571B1 (bg) 1995-06-07 1997-11-27 (r)-(z)-1-азабицикло[2.2.1] хептан-3-он,о-[3-(3-метоксифенил)-2-пропинил] оксим малеат като фармацевтично средство

Country Status (25)

Country Link
US (1) US5534522A (ko)
EP (1) EP0839148B1 (ko)
JP (1) JPH11506723A (ko)
KR (1) KR100383031B1 (ko)
CN (1) CN1063181C (ko)
AT (1) ATE187967T1 (ko)
BG (1) BG63571B1 (ko)
CA (1) CA2219753A1 (ko)
CZ (1) CZ286528B6 (ko)
DE (1) DE69605800T2 (ko)
DK (1) DK0839148T3 (ko)
EA (1) EA000381B1 (ko)
EE (1) EE03971B1 (ko)
ES (1) ES2142586T3 (ko)
GE (1) GEP19991874B (ko)
GR (1) GR3032772T3 (ko)
HK (1) HK1018055A1 (ko)
HU (1) HUP9802499A3 (ko)
NO (1) NO308901B1 (ko)
NZ (1) NZ307946A (ko)
PL (1) PL323796A1 (ko)
SK (1) SK282824B6 (ko)
UA (1) UA46032C2 (ko)
WO (1) WO1996040687A1 (ko)
ZA (1) ZA964764B (ko)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9601909A (pt) * 1995-07-13 1999-10-13 Smithkline Beecham Corp N,n-dietil-8,8-dipropil-2-azaspiro(4,5)decano-2-propan amina dimaleato
US6528529B1 (en) 1998-03-31 2003-03-04 Acadia Pharmaceuticals Inc. Compounds with activity on muscarinic receptors
US7544681B2 (en) 2001-09-27 2009-06-09 Ramot At Tel Aviv University Ltd. Conjugated psychotropic drugs and uses thereof
JP4933259B2 (ja) * 2003-10-02 2012-05-16 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー ピロール置換インドリノン化合物の塩および多形
US7741358B2 (en) * 2005-04-14 2010-06-22 N.V. Organon Crystal form of asenapine maleate
MX2007015511A (es) * 2005-06-07 2008-03-06 Univ Ramot Sales novedosas de farmacos sicotropicos conjugados y procesos para prepararlas.
EP2275095A3 (en) 2005-08-26 2011-08-17 Braincells, Inc. Neurogenesis by muscarinic receptor modulation
EP2258358A3 (en) 2005-08-26 2011-09-07 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
JP2009512711A (ja) 2005-10-21 2009-03-26 ブレインセルス，インコーポレイティド Ｐｄｅ阻害による神経新生の調節
CA2625210A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
WO2007134136A2 (en) 2006-05-09 2007-11-22 Braincells, Inc. Neurogenesis by modulating angiotensin
AU2007249435A1 (en) 2006-05-09 2007-11-22 Braincells, Inc. 5 HT receptor mediated neurogenesis
EP2051735B1 (en) 2006-07-17 2012-08-29 Ramot, at Tel Aviv University Ltd. Conjugates comprising a psychotropic drug or a gaba agonist and an organic acid and their use treating pain and other cns disorders
KR20090064418A (ko) 2006-09-08 2009-06-18 브레인셀즈 인코퍼레이션 4-아실아미노피리딘 유도체 포함 조합물
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
WO2009101616A1 (en) 2008-02-11 2009-08-20 Ramot At Tel Aviv University Ltd. Novel conjugates for treating neurodegenerative diseases and disorders
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
AU2010329440A1 (en) 2009-12-09 2012-08-09 Bar-Ilan University Methods of improving cognitive functions
AU2011219529A1 (en) 2010-02-24 2012-08-30 Bar-Ilan University Crystalline forms of the tri-mesylate salt of perphenazine-GABA and process of producing the same
WO2012038963A1 (en) 2010-09-22 2012-03-29 Ramot At Tel-Aviv University Ltd. An acid addition salt of a nortriptyline-gaba conjugate and a process of preparing same
JP5997931B2 (ja) * 2011-05-25 2016-09-28 石原産業株式会社 農園芸用殺菌剤組成物及び植物病害の防除方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5306718A (en) * 1990-03-06 1994-04-26 Warner-Lambert Company Oxime and amine substituted azabicyclo and azocyclo muscarinic agonists and methods of treatment
US5346911A (en) * 1990-03-06 1994-09-13 Warner-Lambert Company Azabicyclo and azacyclo oxime and amine cholinergic agents and methods of treatment

Also Published As

Publication number Publication date
EP0839148A1 (en) 1998-05-06
US5534522A (en) 1996-07-09
EA000381B1 (ru) 1999-06-24
DK0839148T3 (da) 2000-05-22
NO975704D0 (no) 1997-12-05
PL323796A1 (en) 1998-04-27
NO975704L (no) 1998-01-30
BG102078A (en) 1998-11-30
UA46032C2 (uk) 2002-05-15
AU5744996A (en) 1996-12-30
KR100383031B1 (ko) 2003-10-17
WO1996040687A1 (en) 1996-12-19
CZ286528B6 (cs) 2000-05-17
NZ307946A (en) 2001-03-30
EP0839148B1 (en) 1999-12-22
SK282824B6 (sk) 2002-12-03
GR3032772T3 (en) 2000-06-30
HUP9802499A2 (hu) 1999-04-28
JPH11506723A (ja) 1999-06-15
AU697954B2 (en) 1998-10-22
CA2219753A1 (en) 1996-12-19
ZA964764B (en) 1997-01-08
ATE187967T1 (de) 2000-01-15
CN1063181C (zh) 2001-03-14
EA199800007A1 (ru) 1998-06-25
GEP19991874B (en) 1999-12-06
CN1186493A (zh) 1998-07-01
KR19990022572A (ko) 1999-03-25
SK164497A3 (en) 1998-06-03
ES2142586T3 (es) 2000-04-16
DE69605800D1 (de) 2000-01-27
HK1018055A1 (en) 1999-12-10
EE9700316A (et) 1998-06-15
CZ381797A3 (cs) 1998-05-13
EE03971B1 (et) 2003-02-17
HUP9802499A3 (en) 1999-06-28
DE69605800T2 (de) 2000-11-16
NO308901B1 (no) 2000-11-13

Similar Documents

Publication Publication Date Title
BG63571B1 (bg) (r)-(z)-1-азабицикло[2.2.1] хептан-3-он,о-[3-(3-метоксифенил)-2-пропинил] оксим малеат като фармацевтично средство
CA2146007C (en) Substituted quinuclidines
EP1562945B1 (en) 1,4-diazabicyclo(3,2,2)nonane derivatives, preparation and therapeutical use thereof
JP3223192B2 (ja) アザビシクロおよびアザシクロオキシムおよびアミンコリン作働剤
EP0599890B1 (en) Geneserine derivatives as cholinesterase inhibitors
US20080085915A1 (en) Compounds and methods for the treatment of gastrointestinal and central nervous system disorders
KR20040008175A (ko) 5,8,14-트리아자테트라시클로(10.3.1.02,11.04,9)-헥사데카-2(11),3,5,7,9-펜타엔의 시트르산염 및 그의 제약 조성물
FI88162C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara sulfonyldekahydro-8h-isokino/2,1-g//1,6/naftyridiner, deras optiska isomerer samt farmaceutiskt godtagbara salter
JPH04257579A (ja) ４−（２−フェニルエチル）ピペリジン−１−イル基をもつエタノールおよびエタノン誘導体、その製造および治療的応用
EP1451166B1 (en) Citric acid salt of a therapeutic compound and pharmaceutical compositions thereof
AU697954C (en) (R)-(Z)-1-azabicyclo{2.2.1}heptan-3-one,o-{3-(3-methoxypheny l)-2-propynyl}oxime maleate as a pharmaceutical agent
IE911627A1 (en) Novel tricyclic compounds
NZ585833A (en) Stable crystalline salt of (r)-3-fluorophenyl-3,4,5-trifluorobenzylcarbamic acid 1-azabicyclo [2.2.2]oct-yl ester
JP2002542247A (ja) モルフィノイド化合物
JPH10500120A (ja) ムスカリン受容体リガンドとしてのキヌクリジンｎ−オキシドの誘導体
KR20230008120A (ko) (r)-옥시부티닌 하이드로클로라이드의 다형성 형태
MXPA97008337A (en) Maleate (r) - (z) -1-azabiciclo [2.2.1] heptan-3-ona, 0- [3- (3-metoxypenyl) -2-propinyl] -oxymy as an agent farmaceut
KR20200068667A (ko) 고체 형태의 스테모스피로닌 및 이의 염
WO2008146283A2 (en) Novel palonosetron salts and processes for preparation and purification thereof
CA2015282A1 (en) Pyridine derivatives